Found: 31
Select item for more details and to access through your institution.
Tumoral and immune heterogeneity in an anti-PD-1-responsive glioblastoma: a case study.
- Published in:
- Cold Spring Harbor Molecular Case Studies, 2020, v. 6, n. 2, p. 1, doi. 10.1101/mcs.a004762
- By:
- Publication type:
- Article
MRI Radiomic Features to Predict IDH1 Mutation Status in Gliomas: A Machine Learning Approach using Gradient Tree Boosting.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 8004, doi. 10.3390/ijms21218004
- By:
- Publication type:
- Article
The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 19, p. 7358, doi. 10.3390/ijms21197358
- By:
- Publication type:
- Article
Exploiting the Complexities of Glioblastoma Stem Cells: Insights for Cancer Initiation and Therapeutic Targeting.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 15, p. 5278, doi. 10.3390/ijms21155278
- By:
- Publication type:
- Article
Disparities in receipt of modern concurrent chemoradiotherapy in glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2016, v. 128, n. 2, p. 241, doi. 10.1007/s11060-016-2101-5
- By:
- Publication type:
- Article
Letters to the editor.
- Published in:
- Muscle & Nerve, 1993, v. 16, n. 12, p. 1415, doi. 10.1002/mus.880161221
- By:
- Publication type:
- Article
Uveomeningoencephalitis in a human immunodeficiency virus type 2-seropositive patient.
- Published in:
- Annals of Neurology, 1988, v. 23, n. 3, p. 308, doi. 10.1002/ana.410230318
- By:
- Publication type:
- Article
Unveiling YKL-40, from serum marker to target therapy in glioblastoma.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00090
- By:
- Publication type:
- Article
Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.
- Published in:
- British Journal of Haematology, 2004, v. 126, n. 2, p. 202, doi. 10.1111/j.1365-2141.2004.05028.x
- By:
- Publication type:
- Article
Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma.
- Published in:
- PLoS ONE, 2013, v. 8, n. 4, p. 1, doi. 10.1371/journal.pone.0062150
- By:
- Publication type:
- Article
CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac041
- By:
- Publication type:
- Article
Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 6, p. 1893, doi. 10.1007/s00262-023-03381-y
- By:
- Publication type:
- Article
Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma.
- Published in:
- Cancers, 2024, v. 16, n. 3, p. 589, doi. 10.3390/cancers16030589
- By:
- Publication type:
- Article
Multi-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.
- Published in:
- Cancers, 2023, v. 15, n. 4, p. 1037, doi. 10.3390/cancers15041037
- By:
- Publication type:
- Article
U-Net Based Segmentation and Characterization of Gliomas.
- Published in:
- Cancers, 2022, v. 14, n. 18, p. N.PAG, doi. 10.3390/cancers14184457
- By:
- Publication type:
- Article
Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive–like behaviors in mice.
- Published in:
- Nature Medicine, 2010, v. 16, n. 5, p. 598, doi. 10.1038/nm.2125
- By:
- Publication type:
- Article
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.
- Published in:
- Annals of Neurology, 2011, v. 70, n. 1, p. 163, doi. 10.1002/ana.22360
- By:
- Publication type:
- Article
The future of cancer immunotherapy for brain tumors: a collaborative workshop.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Widely metastatic glioblastoma with BRCA1 and ARID1A mutations: a case report.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Gemcitabine induced myositis in patients with pancreatic cancer: case reports and topic review.
- Published in:
- Journal of Neuro-Oncology, 2012, v. 106, n. 1, p. 15, doi. 10.1007/s11060-011-0672-8
- By:
- Publication type:
- Article
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas.
- Published in:
- Journal of Neuro-Oncology, 2011, v. 105, n. 3, p. 607, doi. 10.1007/s11060-011-0628-z
- By:
- Publication type:
- Article
Clinical relevance of 1p and 19q deletion for patients with WHO grade 2 and 3 gliomas.
- Published in:
- Journal of Neuro-Oncology, 2008, v. 88, n. 3, p. 293, doi. 10.1007/s11060-008-9563-z
- By:
- Publication type:
- Article
A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases.
- Published in:
- Journal of Neuro-Oncology, 2008, v. 87, n. 1, p. 85, doi. 10.1007/s11060-007-9491-3
- By:
- Publication type:
- Article
Capecitabine Therapy of Central Nervous System Metastases from Breast Cancer.
- Published in:
- Journal of Neuro-Oncology, 2007, v. 85, n. 2, p. 223, doi. 10.1007/s11060-007-9409-0
- By:
- Publication type:
- Article
Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitors.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1658, doi. 10.1093/neuonc/noaa066
- By:
- Publication type:
- Article
ATIM-31. PHASE I STUDY OF TUMOR TREATMENT FIELDS AND A PERSONALIZED MUTATION-DERIVED TUMOR VACCINE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi8, doi. 10.1093/neuonc/noy148.026
- By:
- Publication type:
- Article
IMMU-60. MAPPING TUMORAL AND IMMUNE HETEROGENEITY IN PD-1 RESPONSIVE GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi135, doi. 10.1093/neuonc/noy148.563
- By:
- Publication type:
- Article
Phase II trial of continuous low-dose temozolomide for patients with recurrent malignant glioma.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 2, p. 242, doi. 10.1093/neuonc/nos295
- By:
- Publication type:
- Article
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas†.
- Published in:
- Neuro-Oncology, 2011, v. 13, n. 11, p. 1244, doi. 10.1093/neuonc/nor117
- By:
- Publication type:
- Article
Planning TTFields treatment using the NovoTAL system-clinical case series beyond the use of MRI contrast enhancement.
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2890-0
- By:
- Publication type:
- Article